Skip to main content
Log in

Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Introduction

Orthodox Jewish women face unique social, cultural, and religious factors that may influence uptake of BRCA1/2 genetic testing. We examined the impact of a web-based decision aid (DA) on BRCA1/2 genetic testing intention/completion among Orthodox Jewish women. We conducted a single-arm pilot study among 50 Orthodox Jewish women who were given access to a web-based DA entitled RealRisks and administered serial surveys at baseline and 1 and 6 months after exposure to the DA. Descriptive statistics were conducted for baseline characteristics and study measures. Comparisons were made to assess changes in study measures over time. Fifty Orthodox Jewish women enrolled in the study with a mean age of 43.9 years (standard deviation [SD] 14.6), 70% Modern Orthodox, 2% with personal history of breast cancer, and 68% and 16% with a family history of breast or ovarian cancer, respectively. At baseline, 27 (54%) participants intended to complete genetic testing. Forty-three participants (86%) completed RealRisks and the 1-month survey and 38 (76%) completed the 6-month survey. There was a significant improvement in BRCA1/2 genetic testing knowledge and decrease in decisional conflict after exposure to the DA. At 1 month, only 20 (46.5%) completed or intended to complete genetic testing (p = 0.473 compared to baseline). While the DA improved genetic testing knowledge and reduced decisional conflict, genetic testing intention/completion did not increase over time. Future interventions should directly address barriers to BRCA1/2 genetic testing uptake and include input from leaders in the Orthodox Jewish community.

ClinicalTrials.gov ID

NCT03624088 (8/7/18).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

No datasets were generated or analysed during the current study.

References

  1. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi jewish breast cancer families. Nat Med 2(11):1179–1183

    Article  CAS  PubMed  Google Scholar 

  2. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi jews. N Engl J Med 336(20):1401–1408

    Article  CAS  PubMed  Google Scholar 

  3. Rubinstein WS (2004) Hereditary breast cancer in jews. Fam Cancer 3(3–4):249–257

    Article  CAS  PubMed  Google Scholar 

  4. Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K et al (2015) Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing. J Natl Cancer Inst 107(1):380

    Article  PubMed  Google Scholar 

  5. Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S et al (2015) Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-jewish community: a randomized controlled trial. J Natl Cancer Inst 107(1):379

    Article  PubMed  Google Scholar 

  6. Grazi RV, Wolowelsky JB (2015) Cultural concerns when Counseling Orthodox jewish couples for genetic screening and PGD. J Genet Couns 24(6):878–881

    Article  PubMed  Google Scholar 

  7. Coleman-Brueckheimer K, Dein S (2011) Health care behaviours and beliefs in hasidic jewish populations: a systematic review of the literature. J Relig Health 50(2):422–436

    Article  PubMed  Google Scholar 

  8. Phillips KA, Warner E, Meschino WS, Hunter J, Abdolell M, Glendon G et al (2000) Perceptions of Ashkenazi jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet 57(5):376–383

    Article  CAS  PubMed  Google Scholar 

  9. Reisel D, Burnell M, Side L, Loggenberg K, Gessler S, Desai R et al (2022) Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study. BJOG 129(6):959–968

    Article  CAS  PubMed  Google Scholar 

  10. Trivedi MS, Colbeth H, Yi H, Vanegas A, Starck R, Chung WK et al (2018) Understanding factors Associated with Uptake of BRCA1/2 genetic testing among Orthodox jewish women in the USA using a mixed-methods Approach. Public Health Genomics 21(5–6):186–196

    Article  PubMed  Google Scholar 

  11. Yi H, Trivedi MS, Crew KD, Schechter I, Appelbaum PS, Chung WK, Allegrante JP, Kukafka R (2024) Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community. Public Health Genomics. 2024 Feb 23. [Epub ahead of print]

  12. Tang EY, Trivedi MS, Kukafka R, Chung WK, David R, Respler L et al Population-based study of attitudes toward BRCA genetic testing among Orthodox jewish women. The breast journal. 2016 Nov 30.

  13. Kukafka R, Pan S, Silverman T, Zhang T, Chung WK, Terry MB et al (2022) Patient and clinician decision support to increase genetic counseling for Hereditary breast and ovarian Cancer syndrome in primary care: a Cluster Randomized Clinical Trial. JAMA Netw Open 5(7):e2222092

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kukafka R, Fang J, Vanegas A, Silverman T, Crew KD (2018) Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting. BMC Med Inf Decis Mak 18(1):134

    Article  Google Scholar 

  15. Sarkar U, Schillinger D, Lopez A, Sudore R (2011) Validation of self-reported health literacy questions among diverse English and Spanish-speaking populations. J Gen Intern Med 26(3):265–271

    Article  PubMed  Google Scholar 

  16. Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM (2007 Sep-Oct) Measuring numeracy without a math test: development of the subjective numeracy scale. Med Decis Mak 27(5):672–680

  17. Armstrong K, Micco E, Carney A, Stopfer J, Putt M (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293(14):1729–1736

    Article  CAS  PubMed  Google Scholar 

  18. Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA: J Am Med Association 275(24):1885–1892

    Article  CAS  Google Scholar 

  19. O’Connor AM (1995 Jan-Mar) Validation of a decisional conflict scale. Med Decis Mak 15(1):25–30

  20. Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ (2007) Validating the theoretical structure of the treatment self-regulation questionnaire (TSRQ) across three different health behaviors. Health Educ Res 22(5):691–702

    Article  PubMed  Google Scholar 

  21. O’Connor A (1995) User Manual: Decisional Self Efficacy Scale [updated in 2005]

  22. Sussner KM, Edwards TA, Thompson HS, Jandorf L, Kwate NO, Forman A et al (2011) Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City. Public Health Genomics 14(6):356–370

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S et al (2019) Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi jewish population: a cohort study. BJOG 126(6):784–794

    Article  CAS  PubMed  Google Scholar 

  24. Lehmann LS, Weeks JC, Klar N, Garber JE (2002 Sep-Oct) A population-based study of Ashkenazi Jewish women’s attitudes toward genetic discrimination and BRCA1/2 testing. Genetics in medicine: official journal of the American College of Medical Genetics. 4(5):346–352

  25. Dorff EN (1997) Jewish theological and Moral reflections on genetic screening: the case of BRCA1. Health Matrix. ;65

Download references

Acknowledgements

This publication was supported by the National Institutes of Health through Grant Numbers KL2TR001874, R01CA226060, P30CA013696, UL1TR000040, and the Susan G. Komen Foundation, through Grant Number PDF16378127. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by MST, HM, and KDC. The first draft of the manuscript was written by MST and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Meghna S. Trivedi.

Ethics declarations

Ethical approval

Subjects have given their written informed consent and the study protocol was approved by the Institutional Review Board at Columbia University.

Competing Interests

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trivedi, M.S., Manley, H., Yi, H. et al. Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women. Familial Cancer (2024). https://doi.org/10.1007/s10689-024-00371-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10689-024-00371-6

Keywords

Navigation